Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition

Heppt M, Heinzerling L, Kaehler K, Forschner A, Kirchberger M, Loquai C, Meissner M, Meier F, Terheyden P, Schell B, Herbst R, Goeppner D, Kiecker F, Rafei-Shamsabadi D, Haferkamp S, Huber M, Utikal J, Ziemer M, Bumeder , Pfeiffer C, Schd-Trcka S, Schmid-Tannwald C, Tietze J, Eigentler T, Berking C (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Book Volume: 15

Pages Range: 14-14

Authors with CRIS profile

Involved external institutions

Universitätsklinikum Schleswig-Holstein (UKSH) Germany (DE) Klinikum Augsburg Germany (DE) Universitätsmedizin Rostock Germany (DE) Ludwig-Maximilians-Universität (LMU) Germany (DE) Universitätsklinikum Tübingen Germany (DE) Universitätsklinikum Freiburg Germany (DE) Charité - Universitätsmedizin Berlin Germany (DE) Goethe-Universität Frankfurt am Main Germany (DE) Universitätsmedizin der Johannes Gutenberg-Universität Mainz Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden Germany (DE) Universitätsklinikum Regensburg Germany (DE) Justus-Liebig-Universität Gießen Germany (DE) Universitätsklinikum Ulm Germany (DE) Universitätsklinikum Mannheim Germany (DE) SRH Wald-Klinikum Gera Germany (DE) HELIOS Kliniken Germany (DE) Universitätsklinikum Leipzig Germany (DE)

How to cite

APA:

Heppt, M., Heinzerling, L., Kaehler, K., Forschner, A., Kirchberger, M., Loquai, C.,... Berking, C. (2017). Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition. (pp. 14-14).

MLA:

Heppt, M., et al. "Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition." 2017. 14-14.

BibTeX: Download